Drug Improves Cognitive Function in Mouse Model of Down Syndrome

An existing FDA-approved drug improves cognitive function in a mouse model of Down syndrome, according to a new study by researchers at the Stanford University School of Medicine.The drug, an asthma medication called formoterol, strengthened nerve connections in the hippocampus, a brain center used for spatial navigation, paying attention and forming new memories, the study said. It also improved contextual learning, in which the brain integrates spatial and sensory information.

http://neurosciencenews.com/neuropharmacology-hippocampus-down-syndrome-284/

The image shows the location of the hippocampus in the human brain.